Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SHE:300760)
China · Delayed Price · Currency is CNY 158.88
-2.74 (-1.70%)
Jul 31, 2026, 3:05 PM CST
SHE:300760 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 33,397 | 33,282 | 36,726 | 34,932 | 30,366 | 25,270 |
Revenue Growth | -6.16% | -9.38% | 5.13% | 15.04% | 20.17% | 20.18% |
Gross Profit Gross Profit Growth | 19,772 | 19,755 | 22,959 | 22,164 | 19,410 | 16,303 |
Operating Income Operating Income Growth | 9,247 | 9,299 | 12,373 | 12,261 | 10,409 | 8,764 |
Net Income Net Income Growth | 7,837 | 8,136 | 11,668 | 11,582 | 9,607 | 8,002 |
Earnings Per Share EPS Growth | 6.47 | 6.71 | 9.63 | 9.56 | 7.94 | 6.59 |
EPS Growth | -29.66% | -30.30% | 0.79% | 20.42% | 20.50% | 20.28% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
China China Growth | 15,632 | 20,292 | 21,382 | 18,667 | 15,259 |
Asian-Pacific Asian-Pacific Growth | 3,618 | 3,659 | 2,638 | 2,281 | 2,174 |
Europe Europe Growth | 3,374 | 2,887 | 2,191 | 1,998 | 2,268 |
Latin America Latin America Growth | 2,982 | 2,804 | 2,422 | 2,097 | 1,568 |
North America North America Growth | 2,702 | 2,636 | 2,603 | 2,461 | 1,872 |
Others Others Growth | 4,974 | 4,446 | 3,696 | 2,862 | 2,129 |
Total Total Growth | 33,282 | 36,726 | 34,932 | 30,366 | 25,270 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 18,089 | 17,941 | 16,644 | 18,787 | 23,186 | 15,361 |
Total Debt Total Debt Growth | 342.96 | 349.28 | 298.49 | 294.93 | 236.52 | 237.24 |
Net Cash (Debt) Net Cash Growth | 17,746 | 17,592 | 16,346 | 18,492 | 22,949 | 15,124 |
Net Cash Growth | 1.92% | 7.62% | -11.61% | -19.42% | 51.74% | -4.67% |
Net Cash Per Share Net Cash Per Share Growth | 14.64 | 14.52 | 13.49 | 15.26 | 18.96 | 12.45 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 10,032 | 10,145 | 12,432 | 11,062 | 12,141 | 8,999 |
Capital Expenditures CapEx Growth | -2,141 | -2,038 | -1,959 | -2,689 | -1,916 | -1,402 |
Free Cash Flow Free Cash Flow Growth | 7,890 | 8,107 | 10,473 | 8,373 | 10,226 | 7,596 |
Free Cash Flow Growth | -12.40% | -22.59% | 25.07% | -18.11% | 34.62% | -1.19% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 59.20% | 59.36% | 62.51% | 63.45% | 63.92% | 64.52% |
Operating Margin | 27.69% | 27.94% | 33.69% | 35.10% | 34.28% | 34.68% |
Pretax Margin | 27.43% | 29.07% | 35.45% | 37.25% | 36.07% | 35.68% |
Profit Margin | 23.47% | 24.45% | 31.77% | 33.16% | 31.64% | 31.66% |
FCF Margin | 23.63% | 24.36% | 28.52% | 23.97% | 33.67% | 30.06% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 4.380 | 4.380 | 6.270 | 5.800 | 4.500 | 3.500 |
Dividend Per Share Growth | -45.05% | -30.14% | 8.10% | 28.89% | 28.57% | 40.00% |
Dividend Yield | 2.76% | 2.32% | 2.54% | 2.12% | 1.55% | 1.02% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 24.57 | 28.31 | 26.43 | 30.34 | 39.78 | 57.71 |
Forward PE | 22.73 | 24.28 | 22.32 | 26.68 | 34.86 | 48.63 |
P/FCF Ratio | 24.35 | 28.41 | 29.45 | 41.97 | 37.37 | 60.79 |
PS Ratio | 5.75 | 6.92 | 8.40 | 10.06 | 12.58 | 18.27 |